CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently announced the launch of label-free live cell imaging services for scientific studies, such as measuring the growth and proliferation of cells at the single-cell level and population level, and counting cells without cell staining.
Amerigo Scientific recently announced the launch of its VITVO for the establishment of in vitro 3D cell culture models for numerous research applications and pre-clinical studies.
Amerigo Scientific recently announced the launch of its new fibrinogen-depleted human platelet lysate-HPL ELAREM™ Perform FD, Research Grade, no heparin required.
Creative Diagnostics announced the launch of several mouse antibacterial monoclonal antibodies for the development of human and mouse anti-bacterial antibody detection kits.
Creative Diagnostics announced the launch of several mouse antibacterial monoclonal antibodies for the development of human and mouse anti-bacterial antibody detection kits.
Creative Diagnostics recently introduced Plaque Reduction Assay services to detect antibodies from testing serum and viruses within diseased materials to diagnose viral infectious diseases.
STEMart has recently introduced Microbial Identification and Strain Typing services with unmatched accuracy from the most relevant bacterial, filamentous fungi, and yeast reference libraries.
CD Bioparticles launched a variety of strong and weak Ion Exchange Magnetic Particles to separate proteins, peptides, antibodies, DNA/RNA, and other biomolecules.
Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes.
Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma.
CD Bioparticles launched a range of near-infra-red (NIR) quantum dots that exhibit excellent optical properties and biocompatibility for biomedical imaging.
Amerigo Scientific recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII for the detection of blood coagulation factor XIII.
Satisfied Users & 
Approved Press Releases
